Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Chu Matsuda is a pioneering surgeon whose work is redefining the standards of minimally invasive oncology, with a specific focus on robotic gastrectomy and colectomy for gastrointestinal cancers. His research provides critical evidence for the superiority of robotic approaches over traditional laparoscopic methods. In a landmark 2022 study, Dr. Matsuda demonstrated through a rigorous propensity score-matched analysis that robotic gastrectomy offers significant advantages over laparoscopic gastrectomy for gastric cancer, a finding that has garnered 54 citations and influenced surgical protocols. He further advanced the field by leading a multi-institutional prospective cohort study in Japan, which established the safety and feasibility of robotic-assisted colectomy for right-sided colon cancer, a procedure only recently covered by national insurance. Dr. Matsuda’s technical virtuosity is showcased in his report of a completely robotic total gastrectomy with thrombectomy and portal vein reconstruction for a rare and aggressive gastric cancer with portal vein tumor thrombus. Additionally, his work on the learning curve for robotic lateral lymph node dissection is guiding the safe adoption of this complex technique for lower rectal cancer. With over 90 total citations, Dr. Matsuda is a leading voice in the global shift toward robotic surgical oncology.